Ajay Khanna
PORTAL HYPERTENSION
x
DEFINITION
 Normal Portal Pressure : 5-10 mm
 Pressure of > 12 mm : Portal Hypertension
 Portal Hypertension is characterized by gradient of >5
mm Hg between portal venous and central venous
pressure.
 At gradient of 8-10 mm Hg – Varices develops
 If gradient >12 mm Hg – Bleeding from varices
ANATOMY
• Hepatic blood flow
• 2/3rd – Portal vein
• 1/3rd – Hepatic artery
• Portal vein length – 6-8 Cm
• Diameter - 13-16 mm
1/3
2/3
Portosystemic Collateral Formation
Lower end of esophagus
Azygos vein Lt gastric V
Umblicus
Ant abd. veins Paraumblical
Lower end Rectum
Middle and Inf Superior Haem.
Haemmorrhoidal V
Retroperitoneum
Bare area of liver
Porta Systemic Collaterals
esophageal and gastric
veins
inferior rectal-anal veins
anterior abdominal wall
veins
retroperitoneal venous
plexus
PATHOPHYSIOLOGY
 Portal pressure = resistant X flow
Resistance to portal flow
Rise in portal pressure
Development of portasystem collaterals
Hyperdynamic circulation
ETIOLOGY
Extrahepatic (Prehepatic/ EHPVO)
 Portal cavernoma
 Portal vein thrombosis (most common cause)
 Splenic vein thrombosis
 Compression from outside
Intrahepatic
 Presinusoidal
 Schistosomiasis (most common cause)
 Primary biliary cirrhosis
 Sinusoidal
 Alcoholic cirrhosis (most common cause)
 Postsinusoidal
 Alcoholic cirrhosis (most common cause)
 Veno-occlusive disease
 Non Cirrhotic Portal Fibrosis
ETIOLOGY (Contd)
 Posthepatic
 Budd-Chiari syndrome (most common cause)
 Right sided heart failure
 Constrictive pericarditis
 High-flow portal hypertension
 Hepatic artery-portal vein fistula
 Splenic arteriovenous fistula
 Massive splenomegaly
 Left Sided Portal Hypertension (Sinistral)
Clinical features
 Bleeding (Upper GI)
 Splenomegaly
 Jaundice
 Encephalopathy
 Ascites
 Growth Retardation
 Coagulopathy
 Recurrent Infection
Examination
 Jaundice
 Hepatomegaly
 Splenomegaly
 Ascites
 Veins on abdominal wall
 Oedema
 Encepahlopathy
 Hernia
INVESTIGATIONS
• Hematological: CBC, Platelet,
• Biochemical: LFT, PT
• Radiological: Triple Phase Portography, MRI, CT
• Ultrasonography/Doppler
• Endoscopy
• Pressure studies
• Liver Biopsy
Barium swallow
multiple irregular filling defects as
“string of beads” or “earthworm”
ESOPHAGOGASTRO DUODENOSCOPY
Grading as per Endoscopy
 Paqet Grading
 Grade I: Small varices without luminal prolapse
 Grade II: Mod. Size varices showing luminal
prolapse along with minimal obscuring of
gastro esophageal junction.
 Grade III: Large varices showing luminal prolapse
substantially obscuring the gastro
esophageal junction.
 Grade IV: Very large varices completely obscuring
gastroesophageal junction.
USG/Doppler USG:
 Portal vein diameter, thrombus, collaterals , splenomegaly &
ascites.
 Portal flow direction and velocity – Hepatopetal/Fugal
 Portosytemic surgical shunt follow up
 To evaluate patency of shunt
 To evaluate direction of flow
Portography:
 Splenoportovenography
 Transhepatic/transjugular
 Umblical portography
 Triple Phase Portography (CT)
 MRI Portograophy
Portal Pressure Measurement
 Wedged hepatic venous pressure
 Occluded Pressure (SOPP/HOPP)
 Splenic pulp pressure
 Catheterization of umbilical vein
Liver Biospy
Laparoscopy
Child’s grade
(Pugh Modification)
Point 1 Point 2 Point 3
Bilirubin mgm/dl <2 2-3 >3
Albumin (gm/dl) >3.5 3-3.5 <3
Ascites None Controlled Uncontrolled
Encephalopathy None Mild Mod-severe
Prothrombin Time* <3 Sec prolonged 3-6 Sec prolonged >6 Sec prolonged
Total : 5-15
Child A < 6 Child B 7-9 Child C 10-15
* In Original Child score it was nutritional status
TREATMENT
Portal hypertension treatment involves three
level of management
 Reduction of portal pressure
 Treatment of complications arising from
portal hypertension
 Variceal bleeding
 Hypersplenism
 Treatment of underlying liver disease and its
complications
TREATMENT OF VARICEAL BLEEDING
 Primary Prophylaxis : No prior H/O bleed
 Propranolol
 EST
 Secondary Prophylaxis
 Propranolol
 EST
 Surgery
Emergency Treatment of Bleed
 Resuscitation
 Pharmacological therapy
 Endoscopic therapy
 Balloon Temponade
 Transjugular intrahepatic portosystemic
shunt (TIPS)
 Surgical treatment
PHARMACOLOGICAL THERAPY
 Beta blockers
 Vasopressin with or without
nitroglycerine
 Glypressin
 Somatostatin / octreotide
 Metoclopramide
 Long acting nitrates
Beta blockers
  bleeding by  cardiac output.
 Dose 20-60 mg bid  25%  in HR.
 Reduces 40% of bleeding episodes
Vasopressin
 vasoconstriction of the splanchnic circulation.
 Dose  0.2 unit/kg wt, dissolved in 200 ml of 5%
dextrose, over 20 minutes.
Disadvantages
 colicky abdominal pain, & diarrhoea .
 Anginal pains, so it is contraindicated in the
elderly.
 Produce temporary control of bleeding in about
80% of cases.
 To prolong its action it is combined with glycine
 (Glypressin).
ENDOSCOPIC THERAPY
 Injection sclerotherapy
 Variceal band ligation
 Gastric variceal injection
 Thrombin injections
EST
Techniques:
 Intravariceal injection
 Paravariceal injection
 Combination of both
intravariceal +
paravariceal injection
Sclerosants :
 5% Ethanolamine oleate
 0.5% sodium polidocanol
 5% sodium morrhuate
 1% to 3% sodium tetradecyl sulphate
 High concentration of alcohol
 3% phenol
ENDOSCOPIC VARICEAL LIGATION (EVL)
 Occludes venous channels
Sessions < sclerotherapy
Same results as sclerotherapy
 complications vs sclerotherapy
Endoscopic treatment of choice
BALLOON TEMPONADE
 Temporary measure
 Hazardous in infants and small children
 Success rate is 80-90%
 Complications : Aspiration pneumonia,
pressure necrosis , obstruction of
pharynx, ulceration of esophagus,
rupture of balloon, re-bleeding after
deflation (60%).
TYPES OF BALLOON TEMPONADE TUBE:
 Sengstaken Black’s more tube
 Linton-Nicholos tube for gastric variceal haemorrhage
 Minnesota tube – 4 lumen tube
TIPS(Transjugular Intrahepatic Porta systemic shunt)
• Shunt between portal vein
and hepatic vein
• Can be used as short term
bridge to liver
transplantation
• Goal – To reduce
portosystemic gradient
< 12 mm Hg
SURGICAL TREATMENT
SHUNT SURGERY
 Prophylactic
 Emergency shunt surgery
 Reduced with advent of other non surgical procedure
 End to side porto-caval shunt preferred
 Elective shunt surgery
Types of Shunt Surgery
 Non Selective
 Portacaval (end to side/ side to side)
 Mesocaval (With or without graft)
 Proximal Leino Renal Shunt
 Spleen preserving Side to side Splenorenal
shunt (Mitra)
 Selective Shunt
 Distal Leino Renal Shunt (Warren)
 Coronary Caval (Inokuchi)
 Porta Caval (SARFEH SHUNT) 8 mm graft
Warren
Distal Leino Renal Shunt
Types of Operation
 Non Shunt Surgery:
 Stapler transection, (Johnston)
 Boerema,
 Milnes Walker
 Suigura and Futagawa,
 Tanner,
 Hassab,
 Liver Transplantation
Non Selective shunt operations
1- Porta-caval operation
End to side Side to side
Porta-caval operation
 very efficient in lowering the portal pressure
 no bleeding occurs from the varices.
disadvantages:
 deprives the liver of portal blood flow 
accelerates the onset of liver failure.
 Recurrent hepatic encephalopathy in 30-50%
of patients.
Proximal spleno-renal shunt
 indicated if the portal
vein is thrombosed or if
splenectomy is
indicated due to
hypersplenism .
 The incidence of
encephalopathy is less
than after porta caval
shunt.
 it is less effective In
preventing further
bleeding.
 If the splenic vein is
less than 1 cm the
anastomosis is liable to
thrombosis.
Mesocaval (Drapanas) shunt
 insertion of a a
synthetic graft as
dacron, or autogenic
vein between the
superior mesenteric
vein and inferior
vena cava.
 The incidence of
thrombosis is high
Selective shunt (Warren shunt)
 The Rt and Lt gastric vessels
are ligated.
 The proximal end of splenic
vein is ligated while the distal
end is anastomosed to the
left renal vein.
 The short gastric veins are
preserved and will selectively
decompress the lower end of
the oesophagus.
 The incidence of
encephalopathy is low, and
the liver functions remain
normal.
SARFEH PARTIAL SHUNT
Non Shunt Surgery
 Stapler Transection (Johnston)
 Boerema Crile
 Milnes Walker
 Suigura Futagawa
 Tanner
 Hassab
 Sugiura and Futagawa procedure
(1973)  Transthoracic
paraesophageal devascularization
and esophageal transaction
combined with an abdominal
component consisting of
splenectomy, devascularization of
upper stomach, vagotomy and
pyeloroplasty
Modified Sugiura procedure  (Ginsberg 1982) –
Abdominal approach. Splenectomy, paraesophageal and
gastric devascularization, vagotomy, stapler esophageal
transaction via gastrostomy and pyeloroplasty.
HYPERSPLENISM
SELECTIVE SPLENIC EMBOLIZATION :
 Splenic immune function is conserved, size of spleen is
reduced and portal flow is maintained.
 Aim of procedure is to infarct 70-80% of splenic tissue.
 Pneumococcal vaccination is given with this therapy and
sometimes long term antibiotics prophylaxis is needed.
SPLENECTOMY:
 Usually not advocated
 Indicated in isolated portal vein thrombosis with recurrent or
life threatening haemorrhage and a massive spleen.
Shunt Procedures
Ascites
 Disordered albumin synthesis and decreased plasma
colloid osmotic pressure caused by hepatocellular
function damage
 Increased capillary filter pressure due to increased portal
hypertension
 Lymph liquid leakage into abdominal cavity from surface
of the liver because of lymph back-flow obstruction
 Salt and water retention by aldosterone and antidiuretic
hormones deactivation disturbance
 Complications of ascites
 Respiratory embarrasement
 Spontaneous bacterial peritonitis
 Hernia
 Investgations:
 SAAG > 1.1 (Serum Ascitic Albumin Gradient)
 Treatment :
 Salt Restriction
 Diuretics
 Paracentesis
 Shunt - Le Veen Shunt, Denver Shunt
 TIPS
 Liver Transplant
Encephalopathy
 Lactulose
 Stop bleeding
 Neomycin
 Enemas
Budd Chiari syndrome
 Syndrome due to obstruction of hepatic
veins
 Causes :
 Spontaneous thrombosis
 Myeloproliferative disorders
 Web
 Neoplasms
 Polycyathemia
 Contraceptive pills
Presentation of
Budd Chiari Syndrome
 Acute :
 Nausea, vomiting, severe pain in Rt hypochondrium,
rapid enlargement of liver, hypotension, death
 Sudden onset
 Rapid development of Ascites, hepatic insufficiency,
oedema, coma
 Chronic
 Cirrhosis, Ascites, Varices, infection, hepatic failure
Classic Triad
Abdominal Pain
Ascites
Hepatomegaly
Treatment of
Budd Chiari Syndrome
 Anticoagulation
 Membrane IVC : Tranatrial Meatotomy
 Meso atrial Shunt : Shunt between Rt. Atrium
and Sup Mesenteric vein

portal hypertension UG class by Prof. Ajay Khanna, IMS, BHU, Varanasi, India

  • 1.
  • 2.
    DEFINITION  Normal PortalPressure : 5-10 mm  Pressure of > 12 mm : Portal Hypertension  Portal Hypertension is characterized by gradient of >5 mm Hg between portal venous and central venous pressure.  At gradient of 8-10 mm Hg – Varices develops  If gradient >12 mm Hg – Bleeding from varices
  • 3.
    ANATOMY • Hepatic bloodflow • 2/3rd – Portal vein • 1/3rd – Hepatic artery • Portal vein length – 6-8 Cm • Diameter - 13-16 mm 1/3 2/3
  • 4.
    Portosystemic Collateral Formation Lowerend of esophagus Azygos vein Lt gastric V Umblicus Ant abd. veins Paraumblical Lower end Rectum Middle and Inf Superior Haem. Haemmorrhoidal V Retroperitoneum Bare area of liver
  • 5.
    Porta Systemic Collaterals esophagealand gastric veins inferior rectal-anal veins anterior abdominal wall veins retroperitoneal venous plexus
  • 6.
    PATHOPHYSIOLOGY  Portal pressure= resistant X flow Resistance to portal flow Rise in portal pressure Development of portasystem collaterals Hyperdynamic circulation
  • 7.
    ETIOLOGY Extrahepatic (Prehepatic/ EHPVO) Portal cavernoma  Portal vein thrombosis (most common cause)  Splenic vein thrombosis  Compression from outside Intrahepatic  Presinusoidal  Schistosomiasis (most common cause)  Primary biliary cirrhosis  Sinusoidal  Alcoholic cirrhosis (most common cause)  Postsinusoidal  Alcoholic cirrhosis (most common cause)  Veno-occlusive disease  Non Cirrhotic Portal Fibrosis
  • 8.
    ETIOLOGY (Contd)  Posthepatic Budd-Chiari syndrome (most common cause)  Right sided heart failure  Constrictive pericarditis  High-flow portal hypertension  Hepatic artery-portal vein fistula  Splenic arteriovenous fistula  Massive splenomegaly  Left Sided Portal Hypertension (Sinistral)
  • 9.
    Clinical features  Bleeding(Upper GI)  Splenomegaly  Jaundice  Encephalopathy  Ascites  Growth Retardation  Coagulopathy  Recurrent Infection
  • 10.
    Examination  Jaundice  Hepatomegaly Splenomegaly  Ascites  Veins on abdominal wall  Oedema  Encepahlopathy  Hernia
  • 11.
    INVESTIGATIONS • Hematological: CBC,Platelet, • Biochemical: LFT, PT • Radiological: Triple Phase Portography, MRI, CT • Ultrasonography/Doppler • Endoscopy • Pressure studies • Liver Biopsy
  • 12.
    Barium swallow multiple irregularfilling defects as “string of beads” or “earthworm”
  • 13.
    ESOPHAGOGASTRO DUODENOSCOPY Grading asper Endoscopy  Paqet Grading  Grade I: Small varices without luminal prolapse  Grade II: Mod. Size varices showing luminal prolapse along with minimal obscuring of gastro esophageal junction.  Grade III: Large varices showing luminal prolapse substantially obscuring the gastro esophageal junction.  Grade IV: Very large varices completely obscuring gastroesophageal junction.
  • 14.
    USG/Doppler USG:  Portalvein diameter, thrombus, collaterals , splenomegaly & ascites.  Portal flow direction and velocity – Hepatopetal/Fugal  Portosytemic surgical shunt follow up  To evaluate patency of shunt  To evaluate direction of flow
  • 15.
    Portography:  Splenoportovenography  Transhepatic/transjugular Umblical portography  Triple Phase Portography (CT)  MRI Portograophy
  • 16.
    Portal Pressure Measurement Wedged hepatic venous pressure  Occluded Pressure (SOPP/HOPP)  Splenic pulp pressure  Catheterization of umbilical vein Liver Biospy Laparoscopy
  • 17.
    Child’s grade (Pugh Modification) Point1 Point 2 Point 3 Bilirubin mgm/dl <2 2-3 >3 Albumin (gm/dl) >3.5 3-3.5 <3 Ascites None Controlled Uncontrolled Encephalopathy None Mild Mod-severe Prothrombin Time* <3 Sec prolonged 3-6 Sec prolonged >6 Sec prolonged Total : 5-15 Child A < 6 Child B 7-9 Child C 10-15 * In Original Child score it was nutritional status
  • 18.
    TREATMENT Portal hypertension treatmentinvolves three level of management  Reduction of portal pressure  Treatment of complications arising from portal hypertension  Variceal bleeding  Hypersplenism  Treatment of underlying liver disease and its complications
  • 19.
    TREATMENT OF VARICEALBLEEDING  Primary Prophylaxis : No prior H/O bleed  Propranolol  EST  Secondary Prophylaxis  Propranolol  EST  Surgery
  • 20.
    Emergency Treatment ofBleed  Resuscitation  Pharmacological therapy  Endoscopic therapy  Balloon Temponade  Transjugular intrahepatic portosystemic shunt (TIPS)  Surgical treatment
  • 21.
    PHARMACOLOGICAL THERAPY  Betablockers  Vasopressin with or without nitroglycerine  Glypressin  Somatostatin / octreotide  Metoclopramide  Long acting nitrates
  • 22.
    Beta blockers  bleeding by  cardiac output.  Dose 20-60 mg bid  25%  in HR.  Reduces 40% of bleeding episodes
  • 23.
    Vasopressin  vasoconstriction ofthe splanchnic circulation.  Dose  0.2 unit/kg wt, dissolved in 200 ml of 5% dextrose, over 20 minutes. Disadvantages  colicky abdominal pain, & diarrhoea .  Anginal pains, so it is contraindicated in the elderly.  Produce temporary control of bleeding in about 80% of cases.  To prolong its action it is combined with glycine  (Glypressin).
  • 24.
    ENDOSCOPIC THERAPY  Injectionsclerotherapy  Variceal band ligation  Gastric variceal injection  Thrombin injections
  • 25.
    EST Techniques:  Intravariceal injection Paravariceal injection  Combination of both intravariceal + paravariceal injection
  • 26.
    Sclerosants :  5%Ethanolamine oleate  0.5% sodium polidocanol  5% sodium morrhuate  1% to 3% sodium tetradecyl sulphate  High concentration of alcohol  3% phenol
  • 27.
    ENDOSCOPIC VARICEAL LIGATION(EVL)  Occludes venous channels Sessions < sclerotherapy Same results as sclerotherapy  complications vs sclerotherapy Endoscopic treatment of choice
  • 28.
    BALLOON TEMPONADE  Temporarymeasure  Hazardous in infants and small children  Success rate is 80-90%  Complications : Aspiration pneumonia, pressure necrosis , obstruction of pharynx, ulceration of esophagus, rupture of balloon, re-bleeding after deflation (60%).
  • 29.
    TYPES OF BALLOONTEMPONADE TUBE:  Sengstaken Black’s more tube  Linton-Nicholos tube for gastric variceal haemorrhage  Minnesota tube – 4 lumen tube
  • 30.
    TIPS(Transjugular Intrahepatic Portasystemic shunt) • Shunt between portal vein and hepatic vein • Can be used as short term bridge to liver transplantation • Goal – To reduce portosystemic gradient < 12 mm Hg
  • 32.
    SURGICAL TREATMENT SHUNT SURGERY Prophylactic  Emergency shunt surgery  Reduced with advent of other non surgical procedure  End to side porto-caval shunt preferred  Elective shunt surgery
  • 33.
    Types of ShuntSurgery  Non Selective  Portacaval (end to side/ side to side)  Mesocaval (With or without graft)  Proximal Leino Renal Shunt  Spleen preserving Side to side Splenorenal shunt (Mitra)  Selective Shunt  Distal Leino Renal Shunt (Warren)  Coronary Caval (Inokuchi)  Porta Caval (SARFEH SHUNT) 8 mm graft
  • 35.
  • 36.
    Types of Operation Non Shunt Surgery:  Stapler transection, (Johnston)  Boerema,  Milnes Walker  Suigura and Futagawa,  Tanner,  Hassab,  Liver Transplantation
  • 37.
    Non Selective shuntoperations 1- Porta-caval operation End to side Side to side
  • 38.
    Porta-caval operation  veryefficient in lowering the portal pressure  no bleeding occurs from the varices. disadvantages:  deprives the liver of portal blood flow  accelerates the onset of liver failure.  Recurrent hepatic encephalopathy in 30-50% of patients.
  • 39.
    Proximal spleno-renal shunt indicated if the portal vein is thrombosed or if splenectomy is indicated due to hypersplenism .  The incidence of encephalopathy is less than after porta caval shunt.  it is less effective In preventing further bleeding.  If the splenic vein is less than 1 cm the anastomosis is liable to thrombosis.
  • 40.
    Mesocaval (Drapanas) shunt insertion of a a synthetic graft as dacron, or autogenic vein between the superior mesenteric vein and inferior vena cava.  The incidence of thrombosis is high
  • 41.
    Selective shunt (Warrenshunt)  The Rt and Lt gastric vessels are ligated.  The proximal end of splenic vein is ligated while the distal end is anastomosed to the left renal vein.  The short gastric veins are preserved and will selectively decompress the lower end of the oesophagus.  The incidence of encephalopathy is low, and the liver functions remain normal.
  • 42.
  • 43.
    Non Shunt Surgery Stapler Transection (Johnston)  Boerema Crile  Milnes Walker  Suigura Futagawa  Tanner  Hassab
  • 44.
     Sugiura andFutagawa procedure (1973)  Transthoracic paraesophageal devascularization and esophageal transaction combined with an abdominal component consisting of splenectomy, devascularization of upper stomach, vagotomy and pyeloroplasty Modified Sugiura procedure  (Ginsberg 1982) – Abdominal approach. Splenectomy, paraesophageal and gastric devascularization, vagotomy, stapler esophageal transaction via gastrostomy and pyeloroplasty.
  • 45.
    HYPERSPLENISM SELECTIVE SPLENIC EMBOLIZATION:  Splenic immune function is conserved, size of spleen is reduced and portal flow is maintained.  Aim of procedure is to infarct 70-80% of splenic tissue.  Pneumococcal vaccination is given with this therapy and sometimes long term antibiotics prophylaxis is needed. SPLENECTOMY:  Usually not advocated  Indicated in isolated portal vein thrombosis with recurrent or life threatening haemorrhage and a massive spleen. Shunt Procedures
  • 46.
    Ascites  Disordered albuminsynthesis and decreased plasma colloid osmotic pressure caused by hepatocellular function damage  Increased capillary filter pressure due to increased portal hypertension  Lymph liquid leakage into abdominal cavity from surface of the liver because of lymph back-flow obstruction  Salt and water retention by aldosterone and antidiuretic hormones deactivation disturbance
  • 47.
     Complications ofascites  Respiratory embarrasement  Spontaneous bacterial peritonitis  Hernia  Investgations:  SAAG > 1.1 (Serum Ascitic Albumin Gradient)  Treatment :  Salt Restriction  Diuretics  Paracentesis  Shunt - Le Veen Shunt, Denver Shunt  TIPS  Liver Transplant
  • 48.
    Encephalopathy  Lactulose  Stopbleeding  Neomycin  Enemas
  • 49.
    Budd Chiari syndrome Syndrome due to obstruction of hepatic veins  Causes :  Spontaneous thrombosis  Myeloproliferative disorders  Web  Neoplasms  Polycyathemia  Contraceptive pills
  • 50.
    Presentation of Budd ChiariSyndrome  Acute :  Nausea, vomiting, severe pain in Rt hypochondrium, rapid enlargement of liver, hypotension, death  Sudden onset  Rapid development of Ascites, hepatic insufficiency, oedema, coma  Chronic  Cirrhosis, Ascites, Varices, infection, hepatic failure Classic Triad Abdominal Pain Ascites Hepatomegaly
  • 51.
    Treatment of Budd ChiariSyndrome  Anticoagulation  Membrane IVC : Tranatrial Meatotomy  Meso atrial Shunt : Shunt between Rt. Atrium and Sup Mesenteric vein